Literature DB >> 21388666

Mast cell-associated alveolar inflammation in patients with atopic uncontrolled asthma.

Cecilia K Andersson1, Anders Bergqvist, Michiko Mori, Thais Mauad, Leif Bjermer, Jonas S Erjefält.   

Abstract

BACKGROUND: A significant proportion of patients with asthma have persistent symptoms despite treatment with inhaled glucocorticosteroids.
OBJECTIVE: We hypothesized that in these patients, the alveolar parenchyma is subjected to mast cell-associated alterations.
METHODS: Bronchial and transbronchial biopsies from healthy controls (n = 8), patients with allergic rhinitis (n = 8), and patients with atopic uncontrolled asthma (symptoms despite treatment with inhaled glucocorticosteroids; mean dose, 743 μg/d; n = 14) were processed for immunohistochemical identification of mast cell subtypes and mast cell expression of FcεRI and surface-bound IgE.
RESULTS: Whereas no difference in density of total bronchial mast cells was observed between patients with asthma and healthy controls, the total alveolar mast cell density was increased in the patients with asthma (P < .01). Division into mast cell subtypes revealed that in bronchi of patients with asthma, tryptase positive mast cells (MC(T)) numbers decreased compared with controls (P ≤ .05), whereas tryptase and chymase positive mast cells (MC(TC)) increased (P ≤ .05). In the alveolar parenchyma from patients with asthma, an increased density was found for both MC(T) (P ≤ .05) and MC(TC) (P ≤ .05). The increased alveolar mast cell densities were paralleled by an increased mast cell expression of FcεRI (P < .001) compared with the controls. The patients with asthma also had increased numbers (P < .001) and proportions (P < .001) of alveolar mast cells with surface-bound IgE. Similar increases in densities, FcεRI expression, and surface-bound IgE were not seen in separate explorations of alveolar mast cells in patients with allergic rhinitis.
CONCLUSION: Our data suggest that patients with atopic uncontrolled asthma have an increased parenchymal infiltration of MC(T) and MC(TC) populations with increased expression of FcεRI and surface-bound IgE compared with atopic and nonatopic controls.
Copyright © 2011 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21388666     DOI: 10.1016/j.jaci.2011.01.022

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  28 in total

Review 1.  Mast Cell-Mediated Orchestration of the Immune Responses in Human Allergic Asthma: Current Insights.

Authors:  Daniel Elieh Ali Komi; Leif Bjermer
Journal:  Clin Rev Allergy Immunol       Date:  2019-04       Impact factor: 8.667

Review 2.  Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells.

Authors:  Jennine Grootens; Johanna S Ungerstedt; Gunnar Nilsson; Joakim S Dahlin
Journal:  Blood Adv       Date:  2018-09-11

3.  Lin- CD34hi CD117int/hi FcεRI+ cells in human blood constitute a rare population of mast cell progenitors.

Authors:  Joakim S Dahlin; Andrei Malinovschi; Helena Öhrvik; Martin Sandelin; Christer Janson; Kjell Alving; Jenny Hallgren
Journal:  Blood       Date:  2015-12-01       Impact factor: 22.113

4.  Lung Mast Cells Have a High Constitutive Expression of Carboxypeptidase A3 mRNA That Is Independent from Granule-Stored CPA3.

Authors:  Premkumar Siddhuraj; Carl-Magnus Clausson; Caroline Sanden; Manar Alyamani; Mohammad Kadivar; Jan Marsal; Joanna Wallengren; Leif Bjermer; Jonas S Erjefält
Journal:  Cells       Date:  2021-02-03       Impact factor: 6.600

5.  Activated MCTC mast cells infiltrate diseased lung areas in cystic fibrosis and idiopathic pulmonary fibrosis.

Authors:  Cecilia K Andersson; Annika Andersson-Sjöland; Michiko Mori; Oskar Hallgren; Annie Pardo; Leif Eriksson; Leif Bjermer; Claes-Göran Löfdahl; Moises Selman; Gunilla Westergren-Thorsson; Jonas S Erjefält
Journal:  Respir Res       Date:  2011-10-20

Review 6.  Mast Cell-Specific MRGPRX2: a Key Modulator of Neuro-Immune Interaction in Allergic Diseases.

Authors:  Monica Thapaliya; Chalatip Chompunud Na Ayudhya; Aetas Amponnawarat; Saptarshi Roy; Hydar Ali
Journal:  Curr Allergy Asthma Rep       Date:  2021-01-04       Impact factor: 4.919

7.  Controlled and uncontrolled asthma display distinct alveolar tissue matrix compositions.

Authors:  Maria Weitoft; Cecilia Andersson; Annika Andersson-Sjöland; Ellen Tufvesson; Leif Bjermer; Jonas Erjefält; Gunilla Westergren-Thorsson
Journal:  Respir Res       Date:  2014-06-20

8.  Mast Cell Proteases Tryptase and Chymase Induce Migratory and Morphological Alterations in Bronchial Epithelial Cells.

Authors:  Frida Berlin; Sofia Mogren; Julia Tutzauer; Cecilia K Andersson
Journal:  Int J Mol Sci       Date:  2021-05-16       Impact factor: 5.923

9.  Extrafine inhaled corticosteroid therapy in the control of asthma.

Authors:  István Ivancsó; Renáta Böcskei; Veronika Müller; Lilla Tamási
Journal:  J Asthma Allergy       Date:  2013-06-06

Review 10.  Are mast cells instrumental for fibrotic diseases?

Authors:  Catherine Overed-Sayer; Laura Rapley; Tomas Mustelin; Deborah L Clarke
Journal:  Front Pharmacol       Date:  2014-01-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.